Anna Meta Dyrvig Kristensen

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Antiplatelet Therapy

Cardiovascular Events

Coronary Artery Disease

Top Venues

European journal of preventive cardiology

European heart journal. Quality of care & clinical outcomes

European heart journal. Cardiovascular pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, John William McEvoy, Christian Torp-Pedersen, Eva Irene Bossano Prescott
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events. European heart journal. Quality of care & clinical outcomes (2024)
Anna Meta Dyrvig Kristensen, John Munkhaugen, Sigrun Halvorsen, Michael Hecht Olsen, Arnhild Bakken, Thomas Steen Gyldenstierne Sehested, Vidar Ruddox, Theis Lange, Morten Wang Fagerland, Christian Torp-Pedersen, Eva Irene Bossano Prescott, Dan Atar
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics. European heart journal. Cardiovascular pharmacotherapy (2023)
Anna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, Christian Torp-Pedersen, John William McEvoy, Eva Irene Bossano Prescott
Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetes. European journal of preventive cardiology (2023)
Anna Meta Dyrvig Kristensen, Ann Bovin, Ann Dorthe Zwisler, Charlotte Cerquira, Christian Torp-Pedersen, Hans Erik Bøtker, Ida Gustafsson, Karsten Tange Veien, Kristian Korsgaard Thomsen, Michael Hecht Olsen, Mogens Lytken Larsen, Olav Wendelboe Nielsen, Per Hildebrandt, Sussie Foghmar, Svend Eggert Jensen, Theis Lange, Thomas Sehested, Tomas Jernberg, Dan Atar, Borja Ibanez, Eva Prescott
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial. Trials 21 (1) (2020)